142 related articles for article (PubMed ID: 25051330)
1. Repeated intravenous injections in non-human primates demonstrate preclinical safety of an anti-inflammatory phosphorus-based dendrimer.
Fruchon S; Mouriot S; Thiollier T; Grandin C; Caminade AM; Turrin CO; Contamin H; Poupot R
Nanotoxicology; 2015 May; 9(4):433-41. PubMed ID: 25051330
[TBL] [Abstract][Full Text] [Related]
2. Biodistribution and Biosafety of a Poly(Phosphorhydrazone) Dendrimer, an Anti-Inflammatory Drug-Candidate.
Fruchon S; Bellard E; Beton N; Goursat C; Oukhrib A; Caminade AM; Blanzat M; Turrin CO; Golzio M; Poupot R
Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31514434
[TBL] [Abstract][Full Text] [Related]
3. Interaction studies reveal specific recognition of an anti-inflammatory polyphosphorhydrazone dendrimer by human monocytes.
Ledall J; Fruchon S; Garzoni M; Pavan GM; Caminade AM; Turrin CO; Blanzat M; Poupot R
Nanoscale; 2015 Nov; 7(42):17672-84. PubMed ID: 26335052
[TBL] [Abstract][Full Text] [Related]
4. A phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis.
Hayder M; Poupot M; Baron M; Nigon D; Turrin CO; Caminade AM; Majoral JP; Eisenberg RA; Fournié JJ; Cantagrel A; Poupot R; Davignon JL
Sci Transl Med; 2011 May; 3(81):81ra35. PubMed ID: 21543721
[TBL] [Abstract][Full Text] [Related]
5. Curing inflammatory diseases using phosphorous dendrimers.
Caminade AM; Turrin CO; Poupot R
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1783. PubMed ID: 35194953
[TBL] [Abstract][Full Text] [Related]
6. An Anti-Inflammatory Poly(PhosphorHydrazone) Dendrimer Capped with AzaBisPhosphonate Groups to Treat Psoriasis.
Jebbawi R; Oukhrib A; Clement E; Blanzat M; Turrin CO; Caminade AM; Lacoste E; Fruchon S; Poupot R
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32586038
[TBL] [Abstract][Full Text] [Related]
7. Phosphorus-Based Dendrimer ABP Treats Neuroinflammation by Promoting IL-10-Producing CD4(+) T Cells.
Hayder M; Varilh M; Turrin CO; Saoudi A; Caminade AM; Poupot R; Liblau RS
Biomacromolecules; 2015 Nov; 16(11):3425-33. PubMed ID: 26397709
[TBL] [Abstract][Full Text] [Related]
8. Dendrimers to treat rheumatoid arthritis.
Bosch X
ACS Nano; 2011 Sep; 5(9):6779-85. PubMed ID: 21879710
[TBL] [Abstract][Full Text] [Related]
9. Three-Dimensional Directionality Is a Pivotal Structural Feature for the Bioactivity of Azabisphosphonate-Capped Poly(PhosphorHydrazone) Nanodrug Dendrimers.
Hayder M; Garzoni M; Bochicchio D; Caminade AM; Couderc F; Ong-Meang V; Davignon JL; Turrin CO; Pavan GM; Poupot R
Biomacromolecules; 2018 Mar; 19(3):712-720. PubMed ID: 29443507
[TBL] [Abstract][Full Text] [Related]
10. Preclinical studies of dendrimer prodrugs.
Kojima C
Expert Opin Drug Metab Toxicol; 2015; 11(8):1303-15. PubMed ID: 26028253
[TBL] [Abstract][Full Text] [Related]
11. An azabisphosphonate-capped poly(phosphorhydrazone) dendrimer for the treatment of endotoxin-induced uveitis.
Fruchon S; Caminade AM; Abadie C; Davignon JL; Combette JM; Turrin CO; Poupot R
Molecules; 2013 Aug; 18(8):9305-16. PubMed ID: 23921793
[TBL] [Abstract][Full Text] [Related]
12. The ABP Dendrimer, a Drug-Candidate against Inflammatory Diseases That Triggers the Activation of Interleukin-10 Producing Immune Cells.
Fruchon S; Poupot R
Molecules; 2018 May; 23(6):. PubMed ID: 29799517
[TBL] [Abstract][Full Text] [Related]
13. Perspective: Dendrimer drugs for infection and inflammation.
Shaunak S
Biochem Biophys Res Commun; 2015 Dec; 468(3):435-41. PubMed ID: 26168733
[TBL] [Abstract][Full Text] [Related]
14. Phosphorus dendrimers and photodynamic therapy. Spectroscopic studies on two dendrimer-photosensitizer complexes: Cationic phosphorus dendrimer with rose bengal and anionic phosphorus dendrimer with methylene blue.
Dabrzalska M; Zablocka M; Mignani S; Majoral JP; Klajnert-Maculewicz B
Int J Pharm; 2015 Aug; 492(1-2):266-74. PubMed ID: 26117192
[TBL] [Abstract][Full Text] [Related]
15. Inorganic dendrimers: recent advances for catalysis, nanomaterials, and nanomedicine.
Caminade AM
Chem Soc Rev; 2016 Oct; 45(19):5174-86. PubMed ID: 26936375
[TBL] [Abstract][Full Text] [Related]
16. Cationic poly-L-lysine dendrimers: pharmacokinetics, biodistribution, and evidence for metabolism and bioresorption after intravenous administration to rats.
Boyd BJ; Kaminskas LM; Karellas P; Krippner G; Lessene R; Porter CJ
Mol Pharm; 2006; 3(5):614-27. PubMed ID: 17009860
[TBL] [Abstract][Full Text] [Related]
17. Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery.
Souza JG; Dias K; Silva SA; de Rezende LC; Rocha EM; Emery FS; Lopez RF
J Control Release; 2015 Feb; 200():115-24. PubMed ID: 25553828
[TBL] [Abstract][Full Text] [Related]
18. Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: a concise overview.
Mignani S; El Kazzouli S; Bousmina M; Majoral JP
Adv Drug Deliv Rev; 2013 Oct; 65(10):1316-30. PubMed ID: 23415951
[TBL] [Abstract][Full Text] [Related]
19. First-in-Class Phosphorus Dendritic Framework, a Wide Surface Functional Group Palette Bringing Noteworthy Anti-Cancer and Anti-Tuberculosis Activities: What Lessons to Learn?
Mignani S; Bignon J; Shi X; Majoral JP
Molecules; 2021 Jun; 26(12):. PubMed ID: 34204564
[TBL] [Abstract][Full Text] [Related]
20. Poly propyl ether imine (PETIM) dendrimer: a novel non-toxic dendrimer for sustained drug delivery.
Jain S; Kaur A; Puri R; Utreja P; Jain A; Bhide M; Ratnam R; Singh V; Patil AS; Jayaraman N; Kaushik G; Yadav S; Khanduja KL
Eur J Med Chem; 2010 Nov; 45(11):4997-5005. PubMed ID: 20805013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
